Insider · CIK 0001947293
Gemma Brown
Files at BRNS (Barinthus Biotherapeutics plc.). First filing -, latest -.
In brief
Gemma Brown files SEC Form 4 as CFO at BRNS (Barinthus Biotherapeutics plc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Gemma Brown has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 3, 2025 | BRNS Barinthus Biotherapeutics plc. | AGrant or award Share Option (Right to Buy)derivative | +160,000 | $0.00 | $0 | 160,000 | Feb 5, 2025 |
Questions about Gemma Brown
Answered from the filings on this page, as of the latest one.
Is Gemma Brown buying or selling?
Gemma Brown has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Gemma Brown's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Gemma Brown has 0.
Where does Gemma Brown file Form 4?
Gemma Brown has filed Form 4 at BRNS (Barinthus Biotherapeutics plc.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.